JP2023504115A5 - - Google Patents
Info
- Publication number
- JP2023504115A5 JP2023504115A5 JP2022531531A JP2022531531A JP2023504115A5 JP 2023504115 A5 JP2023504115 A5 JP 2023504115A5 JP 2022531531 A JP2022531531 A JP 2022531531A JP 2022531531 A JP2022531531 A JP 2022531531A JP 2023504115 A5 JP2023504115 A5 JP 2023504115A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- approximately
- tadalafil
- selexipag
- macitentan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024118344A JP7620758B2 (ja) | 2019-11-29 | 2024-07-24 | 肺動脈性肺高血圧症の治療方法 |
| JP2025127467A JP2025172745A (ja) | 2019-11-29 | 2025-07-30 | 肺動脈性肺高血圧症の治療方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962941910P | 2019-11-29 | 2019-11-29 | |
| US62/941,910 | 2019-11-29 | ||
| US202063023452P | 2020-05-12 | 2020-05-12 | |
| US63/023,452 | 2020-05-12 | ||
| US202063076149P | 2020-09-09 | 2020-09-09 | |
| US63/076,149 | 2020-09-09 | ||
| PCT/EP2020/083593 WO2021105331A1 (en) | 2019-11-29 | 2020-11-27 | Methods of treating pulmonary arterial hypertension |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024118344A Division JP7620758B2 (ja) | 2019-11-29 | 2024-07-24 | 肺動脈性肺高血圧症の治療方法 |
| JP2025127467A Division JP2025172745A (ja) | 2019-11-29 | 2025-07-30 | 肺動脈性肺高血圧症の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023504115A JP2023504115A (ja) | 2023-02-01 |
| JP2023504115A5 true JP2023504115A5 (cg-RX-API-DMAC10.html) | 2023-12-04 |
| JP7721520B2 JP7721520B2 (ja) | 2025-08-12 |
Family
ID=73726769
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022531531A Active JP7721520B2 (ja) | 2019-11-29 | 2020-11-27 | 肺動脈性肺高血圧症の治療方法 |
| JP2024118344A Active JP7620758B2 (ja) | 2019-11-29 | 2024-07-24 | 肺動脈性肺高血圧症の治療方法 |
| JP2025127467A Pending JP2025172745A (ja) | 2019-11-29 | 2025-07-30 | 肺動脈性肺高血圧症の治療方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024118344A Active JP7620758B2 (ja) | 2019-11-29 | 2024-07-24 | 肺動脈性肺高血圧症の治療方法 |
| JP2025127467A Pending JP2025172745A (ja) | 2019-11-29 | 2025-07-30 | 肺動脈性肺高血圧症の治療方法 |
Country Status (18)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024099953A1 (en) * | 2022-11-07 | 2024-05-16 | Actelion Pharmaceuticals Ltd | Combination of macitentan and tadalafil for the treatment of pulmonary arterial hypertension |
| KR102663470B1 (ko) * | 2023-03-16 | 2024-05-10 | 주식회사 케어사이드 | 폐성 고혈압에 의한 심장 질환 예방 및 심장 치료용 조성물 및 이를 포함하는 기능성 제제 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1693372A1 (en) | 2000-12-18 | 2006-08-23 | Actelion Pharmaceuticals Ltd. | Novel Sulfamides and their use as endothelin receptor antagonists |
| TWI316055B (cg-RX-API-DMAC10.html) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| US20050101608A1 (en) * | 2003-09-24 | 2005-05-12 | Santel Donald J. | Iloprost in combination therapies for the treatment of pulmonary arterial hypertension |
| ES2393117T3 (es) | 2005-09-12 | 2012-12-18 | Actelion Pharmaceuticals Ltd. | Composición farmacéutica estable que comprende una pirimidina-sulfamida |
| AR062501A1 (es) | 2006-08-29 | 2008-11-12 | Actelion Pharmaceuticals Ltd | Composiciones terapeuticas |
| MX350011B (es) | 2008-08-13 | 2017-08-22 | Actelion Pharmaceuticals Ltd | Composiciones terapeuticas que contienen macitentan. |
| SG176915A1 (en) | 2009-06-26 | 2012-01-30 | Nippon Shinyaku Co Ltd | Crystals |
| WO2011024874A1 (ja) | 2009-08-26 | 2011-03-03 | 日本新薬株式会社 | 塩基付加塩 |
| EA026074B1 (ru) | 2010-10-15 | 2017-02-28 | Джилид Сайэнс, Инк. | Способы, включающие применение композиции амбризентана и тадалафила для лечения легочной артериальной гипертензии |
| CN106461677B (zh) * | 2014-04-22 | 2018-09-11 | 国立大学法人东北大学 | 肺高血压病的检查方法 |
| AU2016207046B2 (en) * | 2015-01-13 | 2021-04-01 | Vivus Llc | Combination therapy for pulmonary hypertension |
| RU2763525C2 (ru) * | 2016-10-27 | 2021-12-30 | Пульмокин, Инк. | Комбинированная терапия для лечения легочной гипертензии |
| EP3897646B1 (en) * | 2018-12-21 | 2024-05-22 | Actelion Pharmaceuticals Ltd | Macitentan for the treatment of pulmonary arterial hypertension |
-
2020
- 2020-11-27 IL IL293271A patent/IL293271A/en unknown
- 2020-11-27 PE PE2022000799A patent/PE20221320A1/es unknown
- 2020-11-27 CA CA3158292A patent/CA3158292A1/en active Pending
- 2020-11-27 ES ES20820054T patent/ES2994089T3/es active Active
- 2020-11-27 CN CN202080081138.2A patent/CN114728002A/zh active Pending
- 2020-11-27 CR CR20220305A patent/CR20220305A/es unknown
- 2020-11-27 EP EP20820054.3A patent/EP4065119B1/en not_active Revoked
- 2020-11-27 PH PH1/2022/551294A patent/PH12022551294A1/en unknown
- 2020-11-27 AU AU2020392424A patent/AU2020392424A1/en not_active Abandoned
- 2020-11-27 JO JOP/2022/0127A patent/JOP20220127A1/ar unknown
- 2020-11-27 US US17/780,064 patent/US12485119B2/en active Active
- 2020-11-27 MX MX2022006403A patent/MX2022006403A/es unknown
- 2020-11-27 WO PCT/EP2020/083593 patent/WO2021105331A1/en not_active Ceased
- 2020-11-27 JP JP2022531531A patent/JP7721520B2/ja active Active
- 2020-11-27 TW TW109141697A patent/TW202133851A/zh unknown
- 2020-11-27 BR BR112022010311A patent/BR112022010311A2/pt not_active IP Right Cessation
- 2020-11-27 KR KR1020227017465A patent/KR20220106974A/ko not_active Ceased
-
2022
- 2022-06-28 EC ECSENADI202251163A patent/ECSP22051163A/es unknown
-
2024
- 2024-07-24 JP JP2024118344A patent/JP7620758B2/ja active Active
-
2025
- 2025-07-30 JP JP2025127467A patent/JP2025172745A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1547464B (zh) | 缓释治疗性生物粘附系统 | |
| JP2020529996A5 (cg-RX-API-DMAC10.html) | ||
| EP4633616A1 (en) | Irak4 degraders and uses thereof | |
| CN100594936C (zh) | 改善透粘膜给药制剂的吸收的方法 | |
| De Zeeuw et al. | Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment. | |
| CN113018273A (zh) | 一种固体制剂及其制备方法和用途 | |
| JP2024523559A5 (cg-RX-API-DMAC10.html) | ||
| JP7343478B2 (ja) | 処置の方法 | |
| JPH0667842B2 (ja) | 基本的うつ病を軽減するためのうつ病治療剤 | |
| JP2022031527A (ja) | ピルフェニドンの粒子の大きさ調節による打錠性が改善された薬剤学的組成物およびその製造方法 | |
| TWI783921B (zh) | 手部溼疹之治療 | |
| JP2025504219A5 (cg-RX-API-DMAC10.html) | ||
| JP2022177119A5 (cg-RX-API-DMAC10.html) | ||
| EP2509586B1 (en) | Mucoadhesive buccal tablets for the treatment of orofacial herpes | |
| MX2013005716A (es) | Formulacion de un complejo que comprende clorhidrato de lercanidipina y valsartan y metodo para la preparacion de la misma. | |
| EP4344701A1 (en) | Pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid | |
| EP2535048A1 (en) | Extended release preparation | |
| EP1465607B1 (fr) | Compositions pharmaceutiques a liberation modifiee | |
| WO2018028841A1 (en) | Solid pharmaceutical composition of abacavir, lamivudine, and efavirenz | |
| JP2002531495A (ja) | ウイルス疾患を処置するためのビュープロピオン | |
| CN107205987A (zh) | 根据auc进行奥美沙坦给药的方法 | |
| JP2022550458A5 (cg-RX-API-DMAC10.html) | ||
| US20240415814A1 (en) | Pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid | |
| JP3002766B2 (ja) | 脳浮腫治療剤 | |
| WO2018129463A1 (en) | Co-administration of minocycline and colistin to reduce acute kidney injury |